Clinical Trial Update: A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase I/II trial evaluating intraperitoneal paclitaxel in patients with metastatic appendiceal adenocarcinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Adenocarcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Appendiceal Adenocarcinoma, Intraperitoneal Paclitaxel | Phase 1, Phase 2 | Status: RECRUITING